SRTS: SEC Form 10-Q filed by Sensus Healthcare Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for SRTS
Across the 5 sessions after earlier SRTS headlines, the stock closed higher 4 times and lower 1 times, with a median move of 9.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | SRTS | SPY |
|---|---|---|---|
| Nov 12, 2025 | Sensus Healthcare Appoints Eric Sachetta to its Board of Directors | +9.3% | +0.1% |
| Nov 7, 2025 | Sensus Healthcare Reports Third Quarter 2025 Financial Results | +19.3% | +0.1% |
| Nov 6, 2025 | Sensus Healthcare Named to TIME's America's Growth Leaders of 2026 | -4.6% | -1.1% |
| Nov 4, 2025 | CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer | +12.3% | -1.2% |
| Oct 23, 2025 | Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6 | +2.2% | +0.6% |
Quantisnow market dataNASDAQ
SRTS
Sensus Healthcare Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2016
Get push alerts for SRTS
Full SRTS profile on Quantisnow Follow SRTS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time